关注
Siqi Chen
Siqi Chen
在 coh.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
N (6)‐methyladenosine‐binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay
TL Xia, X Li, X Wang, YJ Zhu, H Zhang, W Cheng, ML Chen, Y Ye, Y Li, ...
EMBO reports 22 (4), e50128, 2021
842021
Harnessing and enhancing macrophage phagocytosis for cancer therapy
S Chen, SWT Lai, CE Brown, M Feng
Frontiers in Immunology 12, 635173, 2021
822021
Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer
X Cao, B Li, J Chen, J Dang, S Chen, EG Gunes, B Xu, L Tian, S Muend, ...
Journal for ImmunoTherapy of Cancer 9 (3), 2021
712021
Bispecific antibodies in cancer immunotherapy
S Chen, J Li, Q Li, Z Wang
Human vaccines & immunotherapeutics 12 (10), 2491-2500, 2016
652016
Mechanistic studies for the role of cellular nucleic-acid-binding protein (CNBP) in regulation of c-myc transcription
S Chen, L Su, J Qiu, N Xiao, J Lin, J Tan, T Ou, L Gu, Z Huang, D Li
Biochimica et Biophysica Acta (BBA)-General Subjects 1830 (10), 4769-4777, 2013
612013
Tumor cell-secreted ISG15 promotes tumor cell migration and immune suppression by inducing the macrophage M2-like phenotype
RH Chen, ZW Xiao, XQ Yan, P Han, FY Liang, JY Wang, ST Yu, TZ Zhang, ...
Frontiers in Immunology 11, 594775, 2020
602020
Warburg effect is a cancer immune evasion mechanism against macrophage immunosurveillance
J Chen, X Cao, B Li, Z Zhao, S Chen, SWT Lai, SA Muend, GK Nossa, ...
Frontiers in immunology 11, 621757, 2021
362021
Single domain antibody-based bispecific antibody induces potent specific anti-tumor activity
J Li, C Zhou, B Dong, H Zhong, S Chen, Q Li, Z Wang
Cancer Biology & Therapy 17 (12), 1231-1239, 2016
342016
A novel bispecific antibody, BiSS, with potent anti-cancer activities
B Dong, C Zhou, P He, J Li, S Chen, J Miao, Q Li, Z Wang
Cancer biology & therapy 17 (4), 364-370, 2016
342016
Interaction of Berberine derivative with protein POT1 affect telomere function in cancer cells
N Xiao, S Chen, Y Ma, J Qiu, JH Tan, TM Ou, LQ Gu, ZS Huang, D Li
Biochemical and Biophysical Research Communications 419 (3), 567-572, 2012
322012
A novel bispecific antibody, S-Fab, induces potent cancer cell killing
L Li, P He, C Zhou, L Jing, B Dong, S Chen, N Zhang, Y Liu, J Miao, ...
Journal of Immunotherapy 38 (9), 350-356, 2015
302015
A targeted IL-15 fusion protein with potent anti-tumor activity
S Chen, Q Huang, J Liu, J Xing, N Zhang, Y Liu, Z Wang, Q Li
Cancer biology & therapy 16 (9), 1415-1421, 2015
252015
Cellular nucleic acid binding protein suppresses tumor cell metastasis and induces tumor cell death by downregulating heterogeneous ribonucleoprotein K in fibrosarcoma cells
J Qiu, S Chen, L Su, J Liu, N Xiao, TM Ou, JH Tan, LQ Gu, ZS Huang, D Li
Biochimica et Biophysica Acta (BBA)-General Subjects 1840 (7), 2244-2252, 2014
252014
Cobalt chloride-induced hypoxia induces epithelial-mesenchymal transition in renal carcinoma cell lines
N Zhang, B Hong, C Zhou, X Du, S Chen, X Deng, S Duoerkun, Q Li, ...
Annals of Clinical & Laboratory Science 47 (1), 40-46, 2017
212017
Targeting tumor-associated macrophages for cancer immunotherapy
X Cao, SWT Lai, S Chen, S Wang, M Feng
International Review of Cell and Molecular Biology 368, 61-108, 2022
162022
A Single Domain–Based Anti-Her2 Antibody Has Potent Antitumor Activities
X Wu, S Chen, L Lin, J Liu, Y Wang, Y Li, Q Li, Z Wang
Translational oncology 11 (2), 366-373, 2018
162018
Pro-phagocytic function and structural basis of GPR84 signaling
X Zhang, Y Wang, S Supekar, X Cao, J Zhou, J Dang, S Chen, L Jenkins, ...
Nature Communications 14 (1), 5706, 2023
122023
UHRF1 controls thymocyte fate decisions through the epigenetic regulation of EGR1 expression
Y Zhang, Y Chen, R Ma, Y Jiang, J Liu, Y Lin, S Chen, M Xia, F Zou, ...
The Journal of Immunology 204 (12), 3248-3261, 2020
112020
Prodrug AST-003 improves the therapeutic index of the multi-targeted tyrosine kinase inhibitor sunitinib
Q Huang, C Zhou, X Chen, B Dong, S Chen, N Zhang, Y Liu, A Li, M Yao, ...
PloS one 10 (10), e0141395, 2015
102015
Non‐Steroidal Anti‐Inflammatory Drugs (NSAIDs) sensitize melanoma cells to MEK inhibition and inhibit metastasis and relapse by inducing degradation of AXL
Y Chen, Y Zhang, S Chen, W Liu, Y Lin, H Zhang, F Yu
Pigment Cell & Melanoma Research 35 (2), 238-251, 2022
82022
系统目前无法执行此操作,请稍后再试。
文章 1–20